GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (LTS:0QIU) » Definitions » Dividend Payout Ratio

Novo Nordisk AS (LTS:0QIU) Dividend Payout Ratio : 0.57 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Novo Nordisk AS Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Novo Nordisk AS's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.57.

The historical rank and industry rank for Novo Nordisk AS's Dividend Payout Ratio or its related term are showing as below:

LTS:0QIU' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33   Med: 0.46   Max: 0.62
Current: 0.47


During the past 13 years, the highest Dividend Payout Ratio of Novo Nordisk AS was 0.62. The lowest was 0.33. And the median was 0.46.

LTS:0QIU's Dividend Payout Ratio is ranked worse than
63.81% of 431 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs LTS:0QIU: 0.47

As of today (2024-12-11), the Dividend Yield % of Novo Nordisk AS is 1.26%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Novo Nordisk AS was 4.17%. The lowest was 0.78%. And the median was 1.77%.

Novo Nordisk AS's Dividends per Share for the months ended in Sep. 2024 was kr3.50.

During the past 12 months, Novo Nordisk AS's average Dividends Per Share Growth Rate was 39.90% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 18.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 12.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 11.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Novo Nordisk AS was 37.70% per year. The lowest was -30.80% per year. And the median was 16.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Novo Nordisk AS Dividend Payout Ratio Historical Data

The historical data trend for Novo Nordisk AS's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Dividend Payout Ratio Chart

Novo Nordisk AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.18 0.46 0.42 0.39

Novo Nordisk AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 - 1.13 - 0.57

Competitive Comparison of Novo Nordisk AS's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Novo Nordisk AS's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk AS's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Novo Nordisk AS's Dividend Payout Ratio falls into.



Novo Nordisk AS Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Novo Nordisk AS's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=7.075/ 18.32
=0.39

Novo Nordisk AS's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=3.5/ 6.12
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novo Nordisk AS (LTS:0QIU) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Novo Nordisk AS Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk AS Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, 2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines